Deb Cromer

Gina Kolata, a medical reporter for The New York Times, shares insights on sickle cell anemia's latest gene therapy developments. Deb Cromer discusses her son Kendrick's inspiring journey as the first to receive this treatment. They explore the emotional and logistical challenges families face, particularly regarding access to this groundbreaking therapy. The conversation highlights hopes for a potential cure while addressing systemic barriers and the importance of awareness in the journey to understanding this condition.

Gina Kolata, a medical reporter for the New York Times, joins Deb Cromer, mother of Kendrick, the first recipient of commercially approved gene therapy for sickle cell anemia. They share Kendrick's journey through this groundbreaking treatment, highlighting the emotional and physical challenges faced by families. The conversation reveals the hopes and fears surrounding this 'cure' and discusses access to innovative healthcare solutions. Deb reflects on her family's resilience, while Kolata emphasizes the importance of empathy in medical care.